Market Place
Sourcing Support
Kyntra Bio To Report 2025 Full-Year Financial Results
09 Mar 2026 //
GLOBENEWSWIRE
Fibrogen Updates Q3 2025 Financials And Business Progress
10 Nov 2025 //
GLOBENEWSWIRE
FibroGen Sells China Branch to AstraZeneca for $220 Million
02 Sep 2025 //
GLOBENEWSWIRE
FibroGen to Present at H.C. Wainwright Global Conference
27 Aug 2025 //
GLOBENEWSWIRE
China Approves FibroGen China Sale to Astra Zeneca
18 Aug 2025 //
GLOBENEWSWIRE
FibroGen to Report Second Quarter 2025 Financial Results
04 Aug 2025 //
GLOBENEWSWIRE
FibroGen Announces 1-for-25 Reverse Stock Split
12 Jun 2025 //
GLOBENEWSWIRE
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to Board
09 Jun 2025 //
GLOBENEWSWIRE
FibroGen Reports Q1 2025 Financial Results and Business Update
12 May 2025 //
GLOBENEWSWIRE
FibroGen to Report First Quarter 2025 Financial Results
05 May 2025 //
GLOBENEWSWIRE
FibroGen at 24th Annual Needham Virtual Healthcare Conference
02 Apr 2025 //
GLOBENEWSWIRE
FibroGen publishes Ph 1 study results of FG-3246 in Prostate Cancer
28 Mar 2025 //
GLOBENEWSWIRE
FibroGen Reports 2024 Financial Results
17 Mar 2025 //
GLOBENEWSWIRE
AstraZeneca boosts China presence with FibroGen`s anemia drug in $160M deal
21 Feb 2025 //
REUTERS
FibroGen Appoints David DeLucia as Chief Financial Officer
16 Dec 2024 //
GLOBENEWSWIRE
FibroGen to Present at H.C. Wainwright 26th Annual Global Conference
03 Sep 2024 //
GLOBENEWSWIRE
FibroGen lays off 75% of US staff as cancer drug flunks 2 more trials
31 Jul 2024 //
FIERCE BIOTECH
FibroGen to Report Second Quarter 2024 Financial Results
30 Jul 2024 //
GLOBENEWSWIRE
FibroGen To Host KOL Investor Event On FG-3246 In Prostate Cancer
18 Jun 2024 //
GLOBENEWSWIRE
FibroGen`s FG-3165 IND Cleared For Solid Tumor Treatment
03 Jun 2024 //
GLOBENEWSWIRE
FibroGen, Regeneron To Evaluate FG-3165, FG-3175 Plus LIBTAYO Combos
03 Jun 2024 //
GLOBENEWSWIRE
FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 Jun 2024 //
GLOBENEWSWIRE
FibroGen to Participate in Upcoming Investor Conferences
07 May 2024 //
GLOBENEWSWIRE
FibroGen Reports First Quarter 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
FibroGen to Report First Quarter 2024 Financial Results
29 Apr 2024 //
GLOBENEWSWIRE
FibroGen, former employees settle dispute over alleged trade secrets theft
20 Apr 2024 //
FIERCE PHARMA
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference
26 Mar 2024 //
GLOBENEWSWIRE
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
11 Mar 2024 //
GLOBENEWSWIRE
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States
26 Feb 2024 //
GLOBENEWSWIRE
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 2024 //
GLOBENEWSWIRE
FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results
20 Feb 2024 //
GLOBENEWSWIRE
FibroGen To Host Part I of Virtual KOL Investor Event Series
05 Feb 2024 //
GLOBENEWSWIRE
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat
09 Dec 2023 //
GLOBENEWSWIRE
FibroGen Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
FibroGen to Report Third Quarter 2023 Financial Results
23 Oct 2023 //
GLOBENEWSWIRE
FibroGen Reports Second Quarter 2023 Financial Results
07 Aug 2023 //
PRESS RELEASE
FibroGen CEO Conterno hits the exit after 3-year stint
25 Jul 2023 //
FIERCE PHARMA
FibroGen to Report Second Quarter 2023 Financial Results
24 Jul 2023 //
GLOBENEWSWIRE
FibroGen lays off 104 employees while ImmuneID restructures
19 Jul 2023 //
FIERCE BIOTECH
FibroGen reports third PhIII failure in idiopathic pulmonary fibrosis
27 Jun 2023 //
ENDPTS
FibroGen faces more trouble in clinic as DMD drug fails phase 3
08 Jun 2023 //
FIERCE BIOTECH
FibroGen to Present at Upcoming Investor Conferences
06 Jun 2023 //
PRESS RELEASE
FibroGen to Present at Jefferies Global Healthcare Conference
06 Jun 2023 //
GLOBENEWSWIRE
FibroGen, AZ`s anemia drug Evrenzo finally chalks up a win
19 May 2023 //
FIERCE PHARMA
FibroGen Announces Positive Results from Pivotal Phase 3 Trial of Roxadustat
18 May 2023 //
GLOBENEWSWIRE
FibroGen Reports First Quarter 2023 Financial Results
08 May 2023 //
GLOBENEWSWIRE
FibroGen’s anemia pill falls short in blood cancer study
06 May 2023 //
BIOPHARMADIVE
FibroGen Announces Results for MATTERHORN, a Ph 3 Clinical Study of Roxadustat
05 May 2023 //
GLOBENEWSWIRE
FibroGen Announces Non-Dilutive Term Loan Financing for up to $150 M
01 May 2023 //
GLOBENEWSWIRE
FibroGen to Report First Quarter 2023 Financial Results
24 Apr 2023 //
GLOBENEWSWIRE
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2
03 Apr 2023 //
GLOBENEWSWIRE
FibroGen to Present at Cowen’s 43rd Annual Health Care Conference
27 Feb 2023 //
GLOBENEWSWIRE
FibroGen Reports Fourth Quarter and Full Year 2022 Financial Results
27 Feb 2023 //
GLOBENEWSWIRE
FibroGen to Report Fourth Quarter and Full Year 2022 Financial Results
17 Feb 2023 //
GLOBENEWSWIRE
FibroGen to Present at SVB Securities Global Biopharma Conference
02 Feb 2023 //
GLOBENEWSWIRE
FibroGen boosted to outperform at Raymond James on fibrosis candidate
26 Jan 2023 //
SEEKING ALPHA
FibroGen Reports Third Quarter 2022 Financial Results
07 Jan 2023 //
GLOBENEWSWIRE
Bank of America upgrades FibroGen to Buy on favorable risk
05 Jan 2023 //
SEEKING ALPHA
AZ`s partner FibroGen slaps former employees with trade secret theft lawsuit
06 Dec 2022 //
FIERCEPHARMA
FibroGen to Participate at Bank of America 2022 Biotech SMID Cap Conference
28 Nov 2022 //
GLOBENEWSWIRE
